Venous leg ulcers
Practitioners must respond appropriately to venous leg ulcers to promote healing and prevent complications.
Venous leg ulcers (VLUs) are the most frequently occurring type of chronic wound, accounting for approximately 80-90 per cent of all lower extremity ulcers. VLUs are a big problem for both patients and health service resources. In the United Kingdom, venous leg ulceration alone has been estimated to cost the NHS £400m a year. In the US, VLUs cause the loss of approximately two million work days per year. A thorough understanding of effective and best practice venous leg ulcer management is therefore imperative for all professionals working in wound care practice.
In this venous leg ulcer supplement, JWC looks at key areas of this topic. These are just a few of the issues addressed in this supplement published by JWC:
- What is the effect of topical corticosteroids on chronic leg ulcer management?
- What is the most cost-effective means for treating and managing patients with chronic VLUs? Are home visits more cost effective than community leg ulcer clinics?
- Can the initial responses to treatment of leg ulcers be used to predict healing times?
- How can innovative drugs (flavonoids, pentoxifylline, capillotropic agents, mesoglycan and prostaglandin) improve chronic venous insufficiency?
- What are the surgical procedures that can reduce the risk of postoperative complications and leg ulcer recurrence?